HAEMONETICS CORP
corporate_fare Company Profile
HAEMONETICS CORP (NYSE:HAE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 9 items for HAE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-18, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for HAE spans 8-K, DEF 14A, 10-K, 10-Q.
Recent high-impact activity:
- Haemonetics Signs Non-Exclusive Supply Agreement with CSL Plasma for NexSys PCS Devices
- Haemonetics Q1 FY27: Revenue +5.6%, Adjusted EPS $1.14, Raises Full-Year Guidance
- Haemonetics Seeks Shareholder Approval for Significant Equity Plan Expansion
- Haemonetics Reports 42% Net Income Drop, $86.5M Intangible Asset Impairment in FY26 Annual Report
- Haemonetics Projects 4%-7% Revenue, EPS Growth for FY27
Financial Snapshot
Short Interest & Short Volume
5.69 days to coverFINRA reported short interest of 3,424,696 shares in HAE as of the September 15, 2026 settlement, a 19.6% increase from the prior period — about 5.7 days to cover at its recent average daily volume. On October 2, 2026, 55.3% of HAE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.